Detection of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Melanoma
The tumor antigen chondroitin sulfate proteoglycan 4 (CSPG4) appears to be a use
The tumor antigen chondroitin sulfate proteoglycan 4 (CSPG4) appears to be a useful biomarker to identify melanoma cells and an attractive target to apply antibody-based immunotherapy for the treatment of melanoma. Here we described the reverse transcription-polymerase chain reaction (RT-PCR) method and the immunohistochemical (IHC) staining method to detect the expression of CSPG4 in melanoma cells and tissues.
- 上一篇
Isolation of Novel Markers for Hepatocellular Carcinoma by a Subtraction-Enhanced Display Technique
With an estimated annual incidence of between 250,000 and 1 ...
- 下一篇
A Xenopus Cell-Free System for Analysis of the Chfr Ubiquitin Ligase Involved in Control of Mitotic
The checkpoint protein Chfr delays entry into mitosis in the...
相关文章
